Trajan Group Holdings Limited (TRJ.AX)
ASX · AUD · Healthcare · Medical Instruments & Supplies
A$0.25 (-3.85%) as of
Key statistics
- Market cap
- 38.22M
- Forward P/E
- 6.36
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.1450 – 0.8100
- Beta
- 0.44
- Revenue (TTM)
- 161.38M
- Profit margin
- -0.39%
- Analyst target
- A$0.51667
- Volume
- 91.50k
About Trajan Group Holdings Limited
Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including gas purifiers and filters, inlet liners, syringes, CB emitters, and tubing products, as well as columns, connections, septa, and inlet liners. It also provides sampling products comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro-sampling tools. In addition, the company provides pathology products, such as NBF containers; adhesive and frosted microscope slides; coverslips; microtome blades; biopsy pads; tissue marking dyes and sets; microscope slide storage trays/mailers; microscope slide and cassette storage boxes; and histology wax plus. Further, it offers analytical, automation, life sciences, sampling literature support products. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Ringwood, VIC, Australia
- Employees
- 620
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.